Introduction
New psychoactive substances, including psychedelic substituted phenethylamines, are public health and regulatory challenges [1] . Substituted phenethylamines, similar in structure to mescaline, were found in drug seizures in the European Union [2] . The United States Drug Enforcement Administration (DEA) has categorized some hallucinogenic compounds, including the substituted phenethylamines 2,5-dimethoxy-4-methylphenethylamine (2C-D), and 2,5-dimethoxy-4-ethylphenethylamine (2C-E) as Schedule 1 substances, i.e., having no therapeutic use and having high potential for abuse and adverse health effects [3] . Recently developed N-benzylmethoxy (NBOMe) compounds are derivatives of the 2C-X family of phenethylamine hallucinogens (see Fig. 1 ) [4, 5] . The drugs are administered orally or sublingually/buccally, available via the internet and known as "n-bomb" [4] . There are several case reports of abuse of 25B-NBOMe, 25C-NBOMe, and 25I-NBOMe and their harmful effects include prolonged agitation, hallucinations, seizures, rhabdomyolysis, acute kidney injury and death [6] [7] [8] [9] [10] . In animal studies, these three NBOMe compounds substituted for the discriminative stimulus effects of the hallucinogen DOM [11] and were recently categorized as Schedule 1 compounds [12] . There is much less information available regarding other NBOMe compounds although anectodal evidence indicates that many are psychoactive and hallucinogenic. 25D-NBOMe, 25E-NBOMe and 25H-NBOMe ( Fig. 1 ) have been detected on commercially available blotter paper [13, 14] and the latter was detected in postmortem blood and urine [15] . 25I-NBOH ( Fig. 1 ) has been found on blotter paper [16] and is an N-hydroxybenzyl derivative of the hallucinogen 2C-I, the demethylated analog of 25I-NBOMe.
Agonist activation of 5-HT 2A receptors is essential for hallucinogenic activity of serotonergic compounds such as LSD and (−)2,5-dimethoxy-4-methylamphetamine (DOM) [17] [18] [19] . Conformational changes of 5-HT 2A receptors induced by the binding of LSD are critical for its time course [20] . For the substituted phenethylamine 2,5-dimethoxy-4-propylthiophenethylamine (2C-T-7), antagonists of 5-HT 2A receptors can decrease drug-induced head twitch behavior in mice and its ability to substitute for the discriminative stimulus properties of LSD in rats [21] . The psychoactive dimethoxyphenethylamine series of compounds, including 2C-D, 2C-E, 2C-I and 2C-T-2 [22] and others, have high affinity and potency at the 5-HT 2A receptor and many of these compounds also bind and have high potency agonist activity at additional 5-HT receptors [23, 24] . Addition of the NBOMe substituent increases the affinity for the 5-HT 2A receptor [5, [24] [25] [26] . The potential interaction of these drugs with the 5-HT 2B receptor is of concern, as prolonged activation by agonists at this receptor can cause cardiac valvulopathy [27, 28] . The role of the 5-HT 2C receptor activation in the psychoactivity of hallucinogens is less well understood (Reviewed in [19] ).
The hallucinogenic activity of the NBOMe and NBOH series is indicated by animal studies. A structurally similar compound, 2-([2-(rcyano-2,5-dimethoxyphenyl)ethylamine]methyl)phenyl (25CN-NBOH) is a 5-HT 2A receptor agonist, causes head twitches in mice that are inhibited by a 5-HT 2A antagonist and substitutes partially for the discriminative stimulus of 2,5-dimethoxy-4-iodoamphetamine (DOI) . 25I-NBOMe is more potent at inducing head twitches than the parent compound 2C-I [30] mobilization assays and have low-mid micromolar affinities for the dopamine, serotonin and norepinephrine transporters (DAT, SERT and NET, respectively) [24] . However, the latter report involved the use of antagonist ligands at the 5-HT 2A and 5-HT 2C receptors and an agonist ligand at the 5-HT 1A receptor. The goal of this research was to characterize the pharmacological activity of 25D-NBOMe, 25E-NBOMe, 25H-NBOMe, 25I-NBOH and 25N-NBOMe at relevant receptors and transporters to aid in the determination of abuse potential and DEA scheduling decisions. We now report results of experiments characterizing the interactions of NBOMe analogues with agonist ligand binding sites and signal transduction across four 5-HT receptors. The specific aims were to 1) determine the affinities of four NBOMe compounds and 25I-NBOH for the 5-HT 1A , 5-HT 2A , 5-HT 2B and 5-HT 2C receptors using agonist radioligands, as well as affinities for the DAT, SERT and NET, 2) determine the potencies and efficacies of the compounds as agonists in functional assays for the 5-HT 1A , 5-HT 2A , 5-HT 2B and 5-HT 2C receptors, and 3) determine the potencies and efficacies of the compounds in uptake and release assays with DAT, SERT and NET.
Materials and methods

Drugs
25D-NBOMe, 25E-NBOMe, 25H-NBOMe, 25I-NBOH and 25N-NBOMe were purchased from Cayman Chemicals (Ann Arbor, MI). (+) The reaction was incubated for 1 h at 25°C and terminated as described above. Agonist efficacy is expressed relative to that of 100 nM 5-HT, which was determined for each experiment. acid, 5 mM CaCl 2 , 10 µM pargyline). The assay was incubated for 45 min at 37°C and terminated as described above. Nonspecific binding was determined with 10 µM serotonin.
5-HT
5-HT 2A, 5-HT 2B and 5-HT 2C receptors: inositol monophosphate (IP-1) formation
Activation of 5-HT 2A (passage numbers 9-17), 5-HT 2B (passage numbers 4-8), and 5-HT 2C receptors (passage numbers 7-10) was tested by measuring the accumulation of inositol monophosphate using the Cisbio IP-1 Elisa kit as described previously [23, 32] . Briefly, cells were plated at a density of 400,000 cells per well in 24 well plates. The next day, cells were starved with DMEM for 1 h, medium was removed, and stimulation buffer was added. After 10 min incubation, agonists were added and plates were incubated for 60 min. Cells were lysed, and 50 μl aliquots of the lysates were added to the IP-1 plate. The assay was conducted according to kit instructions. Stimulated IP-1 formation was normalized to the maximal effect of 5-HT, which was determined in each assay.
Biogenic amine transporters: inhibition of [
125 I]RTI-55 binding to, and
neurotransmitter uptake by, hDAT, hSERT or hNET in clonal cells
The methods for characterizing radioligand binding and functional uptake assays have been described previously [33] . Human embryonic kidney (HEK-293) cells expressing the recombinant hDAT (HEK-hDAT, passage numbers 7, 9, 10, 17, 18, 28), hSERT (HEK-hSERT, passage numbers 11, 15, 16, 18, 20, 26) 
Biogenic amine transporters: [ 3 H]neurotransmitter release
The methods for characterizing drug-induced release of pre-loaded [ 3 H]neurotransmitter from HEK-hDAT (passage numbers 24, 26, 27) , HEK-hSERT (passage numbers [13] [14] [15] [16] [17] [18] [19] and HEK-hNET (passage numbers 18, 19, 22-25) cells have been described previously [32] . In brief, cells were loaded with [ 3 H]neurotransmitter, centrifuged, resuspended in Krebs HEPES buffer (pH 7.4; 122 mM NaCl, 2.5 mM CaCl 2 , 1.2 mM MgSO 4 , 10 μM pargyline, 100 μM tropolone, 0.2% glucose and 0.02% ascorbic acid, buffered with 25 mM HEPES), and added to the superfusion device (Brandel, Gaithersburg, MD). Buffer was perfused for 12-15 min, and the last 6 min (3 fractions) were collected for baseline. Drug was added, and 11 × 2 min fractions of effluent were collected. SDS (1%) was then perfused, and 4 × 2.5 min fractions were collected. Data were normalized to the maximal effects of the positive control METH. Radioactivity in the samples was determined using conventional liquid scintillation spectrometry. Fractional release was the amount of radioactivity in a fraction divided by the total radioactivity remaining in the sample.
Data analysis
For competition binding assay results, data were normalized to the specific binding in the absence of drug. Three or more independent competition experiments were conducted with duplicate determinations. GraphPAD Prism (La Jolla, CA) was used to analyze the ensuing data, with IC 50 values converted to K i values using the Cheng-Prusoff equation [34] . For signal transduction assays, GraphPAD Prism was used to calculate EC 50 values using data expressed as % 5-HT-stimulation for 5 
Results
5-HT 1A receptors
At the recombinant 5-HT 1A receptor, 25D-NBOMe, 25E-NBOMe, 25H-NBOMe, 25I-NBOH, 25N-NBOMe and DOM had lower affinities compared to 5-HT (ps < 0.0001, one way ANOVA followed by Dunnett's multiple comparison test) and LSD had a similar affinity to that of 5-HT ( (Fig. 3D) . (n) Number of independent experiments conducted in duplicate. * Drug-induced stimulation is normalized to the maximal stimulation by 5-HT. (Table 3 ). All had higher affinities for SERT than for DAT or NET. LSD had mid-micromolar affinity and DOM had no measurable affinity, and cocaine and mazindol had mid-nanomolar Ki values. The -NBOMe compounds had IC 50 values for inhibition of [ 3 H]5-HT uptake that were similar to their Ki values. 25D-NBOMe, 25E-NBOMe, 25I-NBOH, and 25N-NBOMe had higher potencies at the recombinant SERT compared to their potencies at DAT or NET. 25H-NBOMe had a rank order of potency of NET > SERT > DAT. There was no measurable effect of LSD, while DOM had midmicromolar and cocaine and mazindol had mid-and low-nanomolar are from [23] . Table 3 Affinity and potency of substituted phenethylamines and other compounds at recombinant hDAT, hSERT and hNET. (Table 4) . Thus, even though the compounds were efficacious at inhibition of uptake at 1-5 µM at SERT (Table 3) , they did not induce release, and thus are blockers, not substrates, at SERT. METH was efficacious at all three transporters, with potencies that agree with previous reports [35] .
Discussion
25D-NBOMe, 25E-NBOMe, 25H-NBOMe, 25I-NBOH, and 25N-NBOMe had very high affinities for the 5-HT 2A receptor, in the subnanomolar range, except for 25H-NBOMe, which had low nanomolar affinity. These affinities are higher (3-5 fold) than those reported [24] using an antagonist radioligand. This difference is consistent with [26] , in that many substituted phenethylamines in the 25H and 25I families show lower affinity for the 5-HT 2A receptor when displacing an antagonist compared to displacement of agonist radioligand. In 5-HT 2A functional assays, these compounds had very high potency at inducing the accumulation of inositol phosphates (IP-1 assay). These EC 50 values were 12-320 times lower (higher potency) than those reported by [24] , which were measured using a Ca 2+ mobilization assay. For 25H-NBOMe and 25I-NBOH, Braden et al. [26] reports EC 50 values in a radiolabeled inositol phosphate accumulation assay similar to or about three fold lower than the values reported herein. In addition, we observed full functional efficacy for the five compounds, ranging from 86 to 95% of maximal serotonin effect, in agreement with [26] and much higher efficacy than in the Ca 2+ mobilization assay [24] . Thus these compounds may be of high concern when considering the possibility of overdose and adverse effects resulting from high potency and full efficacy at the 5-HT 2A receptor. 25D-NBOMe, 25E-NBOMe had sub-nanomolar, 25H-NBOMe had low nanomolar, and 25I-NBOH and 25N-NBOMe had about 1 nM affinity for the 5-HT 2C receptor. These affinities are higher (4-23 fold) than those reported by [24] who used an antagonist radioligand. This is the first report that, in 5-HT 2C functional assays, these compounds had very high potency for inducing the accumulation of inositol phosphates (IP-1 assay). In addition, we observed full functional efficacy for the five compounds, ranging from 91.8 to 99.4% of maximal 5-HT effect. The role of the 5-HT 2C receptor in the psychoactive properties of the substituted phenethylamines is still debatable. A 5-HT 2C antagonist does not, but a 5-HT 2A antagonist does, modify head twitch behavior by 25CN-NBOH [29] . The affinities of 5-HT 2A receptor antagonists correlate with their IC 50 values for blockade of LSD and DOM as stimuli in drug discrimination studies, while the drugs' affinities for the 5-HT 2C receptor do not correlate with the behavioral data [17] . However, activation of 5-HT 2C receptors can activate differentially distinct signal transduction pathways, dependent on agonist characteristics, which may contribute to psychoactive properties of these compounds [36] . For example, Canal and Murnane recently hypothesized that the nonaddictive nature of many hallucinogens is due to 5-HT 2C receptor activation inhibiting potassium Kv1.c channels on nucleus accumbens medium spiny neurons [37] .
Hallucinogenic indoleamines depress raphe cell firing by binding with high affinity to somatodendritic 5-HT 1A autoreceptors (reviewed in [19] ). However, the phenethylamines have very low affinity for 5-HT 1A receptors, and thus do not directly mediate this effect. In addition, although these compounds had high affinity for the 5-HT 2B receptor, they had 11-146 times lower potencies at activating 5-HT 2B compared to 5-HT 2A receptors, and only partial efficacy, which suggests that they could cause cardiac valvulopathy only with chronic and high dose use [28] .
Forensic evidence indicates that relevant brain concentrations for 5-HT 2A activation are reached following drug ingestion. Human blood concentrations, taken hours after ingestion, of 0.29 ng/ml 25H-NBOMe and 2.80 ng/ml 25C-NBOMe have been measured [15] . The ∼0.9 nM 25H-NBOMe blood concentration is lower than its EC 50 for 5-HT 2A IP-1 hydrolysis (40.7 nM) but the ∼8 nM 25I-NBOMe concentration is higher than its EC 50 [26] and similar concentrations have been reported for 25B-NBOMe [38] . Postmortem analysis of peripheral blood and brain tissue yielded 25I-NBOMe concentrations of 0.405 ng/ml and 2.54 ng/g, respectively, suggesting preferential distribution to, and accumulation in, brain tissue [39] . Thus brain concentrations sufficient to activate the 5-HT 2A and 5-HT 2C receptors may have been attained. Serum concentrations for other compounds tested herein were not found in the literature.
Consistent with other reports [26, 30, 40] , affinity for some 5-HT receptors increased with the N-benzyl additions to the phenethylamines. For parent compounds of 25D-NBOMe, 25E-NBOMe and 25I-NBOH at 5-HT 1A , 5-HT 2A and 5-HT 2C receptors, using the same assay conditions, 2C-D had affinities of 1630, 23.9 and 12.7 nM; 2C-E had affinities of 1190, 4.5, and 5.4 nM; and 2C-I had affinities of 970, 9.3, 10.2 nM, respectively [23] . Comparison of these values with Ki values for the corresponding -NBOMe and -NBOH analogs (Table 1) indicates that affinities for 5-HT 1A were decreased while 5-HT 2A affinities were increased 35-100 times by addition of -NBOMe and -NBOH moieties, and 5-HT 2C affinities were increased 10-18 times, similar to affinity shifts of other -NBOMe [41] . Thus the affinity selectivity for the 5-HT 2A receptor was increased with the N-benzyl additions. Modelling of -NBOMe compounds indicates that the increase in 5-HT 2A affinities is due to stabilization of the N-benzyl moiety with Phe339 in transmembrane 6 [26] . In Fig. 3 , the -NBOMe series is grouped to the left with high affinity and potency for both 5-HT 2A and 5-HT 2C receptors . Selectivity for binding affinity for 5-HT 2A over 5-HT 1A ranged from 920 to 20,500 fold across -NBOMe drugs, and between 5-HT 2A and 5-HT 2C ranged from 2.4 to 7.4 fold ( Table 1) . There was also a high selectivity (n) Number of independent experiments. * Maximum release is defined as the maximum release (maximal AUC) induced by METH (1-10 μM, hDAT; 0.3-1 mM, hSERT; 0.3-1 μM, hNET) for each experiment.
of functional activity for the -NBOMe and -NBOH analogs for 5-HT 2A over 5-HT 1A receptors (Table 2) , while the potencies at 5-HT 2A and 5-HT 2C were similar. The current results indicate that the -NBOMe and -NBOH substituted phenethylamines examined here are full, very high potency agonists at the 5-HT 2A and 5-HT 2C receptors. The biochemical pharmacology of these compounds is consistent with psychoactive hallucinogenic activity with minimal stimulant activity, as indicated by lower affinities and potencies at neurotransmitter (DA and NE) transporters. At high, toxic doses, these compounds may cause symptoms, including tachycardia and hypertension, that are elicited by activation of additional pathways [6] .
